Your browser doesn't support javascript.
loading
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma.
Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele.
Afiliação
  • Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Beksac M; Department of Hematology, Ankara University School of Medicine, Ankara, Turkey.
  • van der Holt B; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Aquino S; IRCCS Azienda Ospedaliera Universitaria San Martino, IST Instituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Ludwig H; Wilhelminen Cancer Research Institute, c/o Wilhelminenspital, Vienna, Austria.
  • Zweegman S; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Zander T; Medical Oncology, Luzerner Kantonshospital, Luzern, Switzerland.
  • Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli" and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy.
  • Wester R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Hajek R; University Hospital Ostrava, Ostrava, Czech Republic.
  • Pantani L; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," Bologna, Italy.
  • Dozza L; Department of Experimental, Diagnostic and Experimental Medicine, Seràgnoli Institute of Hematology, Bologna University School of Medicine, S. Orsola Malpighi Hospital, Bologna, Italy.
  • Gay F; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Cafro A; ASST Grande Ospedale Metropolitano, Niguarda, Milan, Italy.
  • De Rosa L; Ospedale San Camillo Forlanini, Rome, Italy.
  • Morelli A; Department of Hematology, Transfusion Medicine and Biotechnology Santo Spirito, Civic Hospital, Pescara, Italy.
  • Gregersen H; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.
  • Gulbrandsen N; Department of Hematology, Oslo University Hospital, Oslo, Norway.
  • Cornelisse P; HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Troia R; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Oliva S; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.
  • van de Velden V; Department of Immunology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Wu K; Department of Hematology, ZNA Stuivenberg, Antwerp, Belgium.
  • Ypma PF; Department of Hematology, Haga Ziekenhuis, The Hague, the Netherlands.
  • Bos G; Maastricht University Medical Center, Maastricht, the Netherlands.
  • Levin MD; Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands.
  • Pour L; University Hospital Brno, Brno, Czech Republic.
  • Driessen C; Department of Oncology/Hematology, Kantonsspital, St Gallen, Switzerland.
  • Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Croockewit A; Department of Hematology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Minnema MC; Department of Hematology, University Medical Centre Utrecht, the Netherlands.
  • Waage A; Department of Hematology, St Olav Hospital, Trondheim, Norway.
  • Hveding C; Sahlgrenska University Hospital, Gothenburg, Sweden.
  • van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Offidani M; Clinica di Ematologia, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
  • Palumbo GA; Department of Scienze Mediche Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia," University of Catania, Catania, Italy.
  • Spencer A; Department of Haematology, Alfred Hospital-Monash University, Melbourne, Australia.
  • Boccadoro M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Cavo M; IRCCS S.Orsola-Malpighi, Istituto di Ematologia "Seràgnoli," Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università degli Studi di Bologna, Bologna, Italy.
J Clin Oncol ; 39(32): 3613-3622, 2021 11 10.
Article em En | MEDLINE | ID: mdl-34520219
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos